/Companies

Matrisome Bio

10 employees on LinkedIn · 2 known investors

Find your way into Matrisome Bio

Sign up to see every warm intro you have to Matrisome Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Matrisome Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Matrisome Bio is an oncology biotech developing therapies based on extracellular matrix (ECM) biology, using a protein engineering platform to target the tumor microenvironment. Its work spans multiple modalities including radioligand therapies.

Founders & leadership

NJNoor Jailkhani
Noor JailkhaniCo-Founder and CEO
RHRichard Hynes
Richard HynesCo-Founder / Professor, MIT & HHMI
SBSangeeta Bhatia
Sangeeta BhatiaCo-Founder / Professor, MIT & HHMIVenture Partner at Catalio Capital Management, LP
MGMonica Gostissa
Monica GostissaChief Science OfficerChief Science Officer at Matrisome Bio, an oncology biotech developing extracellular matrix-targeted therapies. Gostissa has extensive background in R&D and drug discovery, including immunology, and has progressed programs through IND submission.
ETEdward Tad Stewart
Edward Tad StewartChief Business OfficerEdward Tad Stewart is Chief Business Officer of Matrisome Bio, a biotech company developing extracellular matrix-based oncology therapies. He brings over two decades of experience in biotech business development, fundraising, and operations across the product development lifecycle.

Investors · 2

Founder mafia

2 people who came through Matrisome Bio went on to found or lead other companies.

Frequently asked questions

What does Matrisome Bio do?
Matrisome Bio is an oncology biotech developing therapies based on extracellular matrix (ECM) biology, using a protein engineering platform to target the tumor microenvironment. Its work spans multiple modalities including radioligand therapies.
Who founded Matrisome Bio?
Matrisome Bio was founded by Noor Jailkhani, Richard Hynes, Sangeeta Bhatia.
Who are Matrisome Bio's investors?
Matrisome Bio's investors include Bold Capital Partners, The Engine Ventures.